Cargando…

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib

Detalles Bibliográficos
Autores principales:	Nyga, Rémy, Simon, Laura, Chouaki, Taieb, Delette, Caroline, Bennis, Youssef, Joseph, Cedric, Marolleau, Jean-Pierre, Slama, Michel, Zogheib, Elie, Maizel, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416860/ https://www.ncbi.nlm.nih.gov/pubmed/30866996 http://dx.doi.org/10.1186/s13054-019-2385-x

Ejemplares similares

Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection
por: Zogheib, Elie, et al.
Publicado: (2017)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

The Warburg Effect as a Type B Lactic Acidosis in a Patient With Acute Myeloid Leukemia: A Diagnostic Challenge for Clinicians
por: Brault, Clément, et al.
Publicado: (2018)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
por: Ferguson, Martin J, et al.
Publicado: (2017)

Invasive Aspergillosis in Patients Treated With Ibrutinib
por: Fürstenau, Moritz, et al.
Publicado: (2020)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment?
por: Ohlstein, Derek H., et al.
Publicado: (2012)

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis
por: Maertens, Johan A., et al.
Publicado: (2023)

Impact of non-dialysis chronic kidney disease on survival in patients with septic shock
por: Maizel, Julien, et al.
Publicado: (2013)

Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole
por: Ader, Florence, et al.
Publicado: (2009)

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
por: Cadranel, J., et al.
Publicado: (2012)

Can yeast isolation be predicted in complicated secondary non-postoperative intra-abdominal infections?
por: Dupont, Hervé, et al.
Publicado: (2015)

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis
por: Janssen, Nico A.F., et al.
Publicado: (2021)

Cerebral aspergillosis and facial acneiform lesions following initiation of ibrutinib in a patient with chronic lymphocytic leukemia
por: Bedier, Helbies, et al.
Publicado: (2021)

Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia
por: Arthurs, Benjamin, et al.
Publicado: (2017)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
por: Sandherr, M, et al.
Publicado: (2011)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
por: Shen, Jiquan, et al.
Publicado: (2020)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
por: Wang, Taotao, et al.
Publicado: (2018)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
por: Grau, Santiago, et al.
Publicado: (2016)

Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia
por: Beresford, Rohan, et al.
Publicado: (2019)

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
por: Krueger, Kem P, et al.
Publicado: (2009)

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole
por: Jacobs, F., et al.
Publicado: (2011)

Efficacy of the Combination of Voriconazole and Caspofungin in Experimental Pulmonary Aspergillosis by Different Aspergillus Species
por: Zhang, Ming, et al.
Publicado: (2013)

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
por: Gu, Li, et al.
Publicado: (2023)

Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy
por: Siciliano, Rinaldo Focaccia, et al.
Publicado: (2012)

Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
por: Harrington, Rachel, et al.
Publicado: (2016)

Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole
por: Teng, Guo-Jie, et al.
Publicado: (2020)

Voriconazole: Lack of efficacy during treatment of invasive pulmonary aspergillosis: 2 case reports
Publicado: (2021)

Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats
por: Lee, Ji-Sang, et al.
Publicado: (2021)

Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
por: Zerbib, Yoann, et al.
Publicado: (2022)

Invasive maxillary sinus aspergillosis: A case report successfully treated with voriconazole and surgical debridement
por: Peral-Cagigal, Beatriz, et al.
Publicado: (2014)

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
por: Martínez-Casanova, Javier, et al.
Publicado: (2018)

Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
por: Floros, Lefteris, et al.
Publicado: (2019)

The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis
por: Kosmidis, Chris, et al.
Publicado: (2020)

1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
por: Le Daré, Brendan, et al.
Publicado: (2021)

Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022)

Immunosuppressants/voriconazole: COVID-19 infection, invasive systemic aspergillosis and visual disturbance: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q17es9i6874jdnhoqctp6u5ubh